CVRdatabase
Menu

Clinical-Microbiomics A/S

Public limited companyCVR 37230634København ØActive

Clinical-Microbiomics A/S is a public limited company, based in København Ø, active in research and experimental development on natural sciences and engineering, founded in 2015. The company made a loss in both 2024 and 2025, most recently DKK 1.3m. With 32 employees, the company is about 6 times larger than the industry median. Gross profit is higher than that of 84% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 13.2m+23.4% vs. 2024
Net profit−DKK 1.3m+86.3% vs. 2024
EquityDKK 81.2m−1.6% vs. 2024
Employees32latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 23% (2024 → 2025), to DKK 13.2m.
  • The loss got smaller: from DKK 9.1m to DKK 1.3m (2024 → 2025).
  • Equity fell 2% (2024 → 2025), to DKK 81.2m.

Employees

  • 3 more employees than a year earlier: 32 (07/2026) against 29 (07/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
  • 08/11/2024: Share capital changed from 2,124,712 DKK to 2,126,111 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 20mDKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120m202020212022202320242025
EquityNet profit
Financial figures for Clinical-Microbiomics A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit17,02416,76918,9876,22110,67213,170+23.4%
Operating profit (EBIT)–−1,368−5,594−2,313−7,280−6,313+13.3%
Profit before tax587−2,550−7,218−2,606−7,798−6,625+15%
Net profit816−1,723−6,909−2,542−9,137−1,253+86.3%
Total assets12,54328,266141,635102,905100,95093,501−7.4%
Equity−3,3302,826119,54385,16082,45281,151−1.6%
Liabilities15,87325,44022,09210,1279,9819,146−8.4%
Cash and cash equivalents7,39810,6218,2881,8222,0502,706+32%
Average number of employees19263282106115+8.5%

Source: annual reports filed with the Danish Business Authority (XBRL). Group figures; change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 2mDKK 4mDKK 6mDKK 8mDKK 10mDKK 12mDKK 14mDKK 16mDKK 18m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 5 years in a row

    Net result has been negative in 2021–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Clinical-Microbiomics A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202526/06/2026The groupPDF not statedXBRL
202401/01/2024 – 31/12/202427/06/2025The groupPDFXBRL
202301/01/2023 – 31/12/202328/06/2024The groupPDFXBRL
202201/01/2022 – 31/12/202204/06/2023The companyPDFXBRL
202101/01/2021 – 31/12/202119/04/2022The companyPDFXBRL
202001/01/2020 – 31/12/202019/04/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
01020304008/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 13.2mNo. 70 of 421
Better than 84% of the companies in the industry
EquityDKK 81.2mNo. 44 of 431
Better than 90% of the companies in the industry
Number of employees32No. 16 of 431
Better than 97% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 4,692of 9,892
Better than 53%
No. 435of 9,922
Better than 96%
Same industry and 20–49 employees64 companies in the comparison
No. 23of 62
Better than 64%
No. 15of 64
Better than 78%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 3,252of 33,588
Better than 90%
No. 822of 33,687
Better than 98%
All companies of type A/S18,025 companies in the comparison
No. 7,763of 17,786
Better than 56%
No. 2,625of 18,024
Better than 85%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Clinical-Microbiomics A/SDKK 13.2m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Clinical-Microbiomics A/S−DKK 1.3m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Clinical-Microbiomics A/SDKK 81.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Clinical-Microbiomics A/S32
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Manjin ApS5%
  • Vendler ApS5%
  • Applied Industries Holding AB33.33%
  • Health For Life Capital II Prima S.C.A. RAIF5%
  • Health For Life Capital II FPCI – Alpha Compartment5%
Clinical-Microbiomics A/S
Subsidiaries and ownership shares

Subsidiaries are shown only if they are in the database.

Management

7 active registrations

Executive management

Executive management at Clinical-Microbiomics A/S
NameRoleAppointed
Anders Christian Neto de Sousa GrønCEO01/10/2021

Board of directors

Board of directors at Clinical-Microbiomics A/S
NameRoleAppointed
Isabelle Valerie de CremouxBoard member01/07/2022
Caroline PopperBoard member02/06/2023
Morten Otto Alexander SommerBoard member09/10/2023
Manoj Nirmal DadlaniChair of the board09/10/2023
Nathan Allen LedeboerBoard member09/10/2023
Bruce Harvey GrantBoard member09/10/2023
Founders
Manjin ApS, Vendler ApS
Former management (14)
Former management at Clinical-Microbiomics A/S
NameRoleAppointedResigned
Rasmus Vendler Toft-KehlerDirector02/11/201501/01/2016
Morten Otto Alexander SommerDirector02/11/201501/01/2016
Rasmus Vendler Toft-KehlerBoard member16/12/201509/10/2023
Dennis Landbo NielsenBoard member16/12/201528/01/2021
Ole SkovChair of the board16/12/201529/10/2017
Morten Otto Alexander SommerBoard member16/12/201528/10/2017
Lone Merete VengCEO01/01/201601/06/2016
Martin Andreas SantiniCEO01/06/201630/09/2021
Henrik DalbøgeBoard member24/08/201609/10/2023
Morten Otto Alexander SommerChair of the board29/10/201708/10/2023
Morten Asser KarsdalBoard member01/11/201928/06/2021
Ole SkovBoard member28/01/202108/06/2021
Thomas AlsbjergBoard member28/01/202109/10/2023
Torben ThomasenBoard member12/10/202209/10/2023

Signing rule: Selskabet tegnes af den administrerende direktør og et bestyrelsesmedlem eller af to bestyrelsesmedlemmer i forening.

Address and production units

2 active production units

Fruebjergvej 3
2100 København Ø

København Municipality · Postcode 2100

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
Clinical-Microbiomics A/SFruebjergvej 3, 2100 København Ø281020898778
MSOBygstubben 9, 2950 Vedbæk21029207166

Purpose

Selskabets formål er at drive kontraktsforskning inden for bioteknologi samt hermed beslægtede aktiviteter.

The purpose is quoted from the register in Danish.

Changes year by year

119 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20248 changescapital 4 · ownership 3 · accounts 1
  • Share capital changed from 2,124,712 DKK to 2,126,111 DKK
  • Health For Life Capital II FPCI – Alpha Compartment registered as owner (5%)
  • Health For Life Capital II Prima S.C.A. RAIF registered as owner (5%)
  • ADSIDIUS ApS is no longer registered as owner
  • Annual report for 2023 published
  • Share capital changed from 2,109,170 DKK to 2,124,712 DKK
  • Share capital changed from 2,043,383 DKK to 2,109,170 DKK
  • Share capital changed from 2,010,929 DKK to 2,043,383 DKK
202326 changescapital 1 · management 10 · ownership 14 · accounts 1
  • Share capital changed from 1,037,614 DKK to 2,010,929 DKK
  • Bruce Harvey Grant appointed board member
  • Nathan Allen Ledeboer appointed board member
  • Manoj Nirmal Dadlani appointed chair of the board
  • Morten Otto Alexander Sommer appointed board member
  • Torben Thomasen stepped down as board member
  • Thomas Alsbjerg stepped down as board member
  • Henrik Dalbøge stepped down as board member
  • Rasmus Vendler Toft-Kehler stepped down as board member
  • ADSIDIUS ApS registered as owner (5%)
  • Applied Industries Holding AB registered as owner (33.33%)
  • VENDLER ApS registered as owner (5%)
  • MANJIN ApS registered as owner (5%)
  • BIRKEHEGNET 13 HOLDING ApS is no longer registered as owner
  • REINHOLDT ENGINEERING ApS is no longer registered as owner
  • TLC HOLDING ApS is no longer registered as owner
  • TAL Invest ApS is no longer registered as owner
  • Verde Family Holding ApS is no longer registered as owner
  • Health For Life Capital II Prima S.C.A. RAIF is no longer registered as owner
  • Health for Life Capital II FPCI - ALPHA Compartment is no longer registered as owner
  • Morten Otto Alexander Sommer stepped down as chair of the board
  • MANJIN ApS is no longer registered as owner
  • ADSIDIUS ApS is no longer registered as owner
  • VENDLER ApS is no longer registered as owner
  • Annual report for 2022 published
  • Caroline Popper appointed board member
202224 changescapital 2 · management 2 · ownership 19 · accounts 1
  • Share capital changed from 846,782 DKK to 1,037,614 DKK
  • Torben Thomasen appointed board member
  • BIRKEHEGNET 13 HOLDING ApS registered as owner (5%)
  • REINHOLDT ENGINEERING ApS registered as owner (5%)
  • DACCO INVEST ApS is no longer registered as owner
  • Share capital changed from 704,300 DKK to 846,782 DKK
  • Isabelle Valerie de Cremoux appointed board member
  • MANJIN ApS registered as owner (10%)
  • TLC HOLDING ApS registered as owner (5%)
  • ADSIDIUS ApS registered as owner (10%)
  • DACCO INVEST ApS registered as owner (5%)
  • VENDLER ApS registered as owner (10%)
  • TAL Invest ApS registered as owner (5%)
  • Verde Family Holding ApS registered as owner (5%)
  • Health For Life Capital II Prima S.C.A. RAIF registered as owner (5%)
  • Health for Life Capital II FPCI - ALPHA Compartment registered as owner (5%)
  • Verde Family Holding ApS is no longer registered as owner
  • DACCO INVEST ApS is no longer registered as owner
  • TAL Invest ApS is no longer registered as owner
  • TLC HOLDING ApS is no longer registered as owner
  • ADSIDIUS ApS is no longer registered as owner
  • MANJIN ApS is no longer registered as owner
  • VENDLER ApS is no longer registered as owner
  • Annual report for 2021 published
202114 changesownership 6 · management 7 · accounts 1
  • Verde Family Holding ApS registered as owner (10%)
  • Clinical-Microbiomics A/S is no longer registered as owner
  • Anders Christian Neto de Sousa Grøn appointed ceo
  • Martin Andreas Santini stepped down as ceo
  • Morten Asser Karsdal stepped down as board member
  • Ole Skov stepped down as board member
  • DACCO INVEST ApS registered as owner (5%)
  • TAL Invest ApS registered as owner (10%)
  • TAL Invest ApS is no longer registered as owner
  • DACCO INVEST ApS is no longer registered as owner
  • Annual report for 2020 published
  • Thomas Alsbjerg appointed board member
  • Ole Skov appointed board member
  • Dennis Landbo Nielsen stepped down as board member
20204 changesownership 3 · address 1
  • TAL Invest ApS registered as owner (5%)
  • DACCO INVEST ApS registered as owner (10%)
  • DACCO INVEST ApS is no longer registered as owner
  • Moved to Fruebjergvej 3, 2100 København Ø
20191 changemanagement 1
  • Morten Asser Karsdal appointed board member
20184 changesownership 4
  • DACCO INVEST ApS registered as owner (15%)
  • TLC HOLDING ApS registered as owner (5%)
  • ADSIDIUS ApS registered as owner (15%)
  • OD Clinical Holding ApS is no longer registered as owner
20173 changesmanagement 3
  • Morten Otto Alexander Sommer appointed chair of the board
  • Ole Skov stepped down as chair of the board
  • Morten Otto Alexander Sommer stepped down as board member
201620 changescapital 2 · management 6 · ownership 10 · address 1 · name 1
  • Share capital changed from 500,000 DKK to 704,300 DKK
  • Henrik Dalbøge appointed board member
  • MANJIN ApS registered as owner (20%)
  • OD Clinical Holding ApS registered as owner (33.33%)
  • Clinical-Microbiomics A/S registered as owner (10%)
  • VENDLER ApS registered as owner (20%)
  • Clinical-Microbiomics A/S is no longer registered as owner
  • OD Clinical Holding ApS is no longer registered as owner
  • VENDLER ApS is no longer registered as owner
  • MANJIN ApS is no longer registered as owner
  • Moved to Ole Maaløes Vej 3, 2200 København N
  • Clinical-Microbiomics A/S registered as owner (15%)
  • Pinnacle Holding ApS is no longer registered as owner
  • Martin Andreas Santini appointed ceo
  • Lone Merete Veng stepped down as ceo
  • Name changed from Clinical-Microbiomics ApS to Clinical-Microbiomics A/S
  • Share capital changed from 63,890 DKK to 500,000 DKK
  • Lone Merete Veng appointed ceo
  • Morten Otto Alexander Sommer stepped down as director
  • Rasmus Vendler Toft-Kehler stepped down as director
201512 changesownership 4 · capital 1 · management 6 · founded 1
  • OD Clinical Holding ApS registered as owner (20%)
  • Share capital changed from 50,000 DKK to 63,890 DKK
  • Dennis Landbo Nielsen appointed board member
  • Morten Otto Alexander Sommer appointed board member
  • Ole Skov appointed chair of the board
  • Rasmus Vendler Toft-Kehler appointed board member
  • Registered as Clinical-Microbiomics ApS
  • Morten Otto Alexander Sommer appointed director
  • Rasmus Vendler Toft-Kehler appointed director
  • VENDLER ApS registered as owner (25%)
  • Pinnacle Holding ApS registered as owner (15%)
  • MANJIN ApS registered as owner (25%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction